Re-evaluating the concept of "dominant/index tumor nodule" in multifocal prostate cancer

Virchows Archiv

Volumn 464, Issue 5, 2014, Pages 589-594

  Huang, Cheng Cheng ^a   Deng, Fang Ming ^a   Kong, Max X ^a   Ren, Qinhu ^a   Melamed, Jonathan ^a   Zhou, Ming ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dominant tumor; Index tumor; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; EXTRAPROSTATIC EXTENSION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NEOPLASM; ONCOLOGICAL PARAMETERS; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR NODULE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84902314787     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-014-1557-y     Document Type: Article

References (40)

1. Greene DR, Wheeler TM, Egawa S et al (1991) A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. J Urol 146:1069-1076
2. Villers A, McNeal JE, Freiha FS et al (1992) Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70:2313-2318
3. Miller GJ, Cygan JM (1994) Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol 152:1709-1713 (Pubitemid 24322612)
4. Arora R, Koch MO, Eble JN et al (2004) Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100: 2362-2366 (Pubitemid 38657883)
5. Cheng L, Jones TD, Pan CX et al (2005) Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens. Mod Pathol 18:1022-1026 (Pubitemid 41224491)
6. Wise AM, Stamey TA, McNeal JE et al (2002) Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 60:264-269 (Pubitemid 34831770)
7. Andreoiu M, Cheng L (2010) Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol 41:781-793
8. Ruijter ET, van de Kaa CA, Schalken JA et al (1996) Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol 180:295-299 (Pubitemid 26393679)
9. Cheng L, Song SY, Pretlow TG et al (1998) Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 90:233-237 (Pubitemid 28114542)
10. Mehra R, Han B, Tomlins SA et al (2007) Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 67:7991-7995 (Pubitemid 47395131)
11. McNeal JE, Price HM, Redwine EA et al (1988) Stage Aversus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 139:61-65 (Pubitemid 18050742)
12. Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228-1242 (Pubitemid 41232997)
13. van der Kwast TH, Amin MB, Billis A et al (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens.Working Group 2: T2 substaging and prostate cancer volume. Mod Pathol 24:16-25
14. Billis A, Freitas LL, Magna LA et al (2004) Prostate cancer with bladder neck involvement: pathologic findings with application of a new practical method for tumor extent evaluation and recurrence-free survival after radical prostatectomy. Int Urol Nephrol 36:363-368
15. Yoon GS, Wang W, Osunkoya AO et al (2008) Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 179:2203-2206
16. Chen ME, Johnston DA, Tang K et al (2000) Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89:1800-1809
17. Magi-Galluzzi C, Evans AJ, Delahunt B et al (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens.Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 24:26-38
18. Tan PH, Cheng L, Srigley JR et al (2011) International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol 24:48-57
19. Bastacky SI, Wojno KJ, Walsh PC et al (1995) Pathological features of hereditary prostate cancer. J Urol 153:987-992
20. Kastendieck H (1980) Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies. Pathol Res Pract 169:366-387
21. Cheng L, Poulos CK, Pan CX et al (2005) Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. J Urol 174:898-902 (Pubitemid 41140625)
22. Byar DP, Mostofi FK (1972) Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30:5-13
23. Qian J, Bostwick DG (1995) The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract 191:860-867
24. Eichelberger LE, Cheng L (2004) Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer 100:2573-2576 (Pubitemid 38715761)
25. Cheng L, Pisansky TM, Ramnani DMet al (2000) Extranodal extension in lymph node-positive prostate cancer.Mod Pathol 13:113-118 (Pubitemid 30109096)
26. Aihara M, Wheeler TM, Ohori M et al (1994) Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 43:60-66, discussion 66-67
27. Bostwick DG, Shan A, Qian J et al (1998) Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 83:1995-2002 (Pubitemid 28503732)
28. Epstein JI, Walsh PC, Carmichael M et al (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368-374 (Pubitemid 24037911)
29. Noguchi M, Stamey TA, McNeal JE et al (2003) Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 170:459-463 (Pubitemid 36870224)
30. Epstein JI (2011) Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 186:790-797
31. Sakr WA, Macoska JA, Benson P et al (1994) Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res 54:3273-3277 (Pubitemid 24208941)
32. Schmidt H, DeAngelis G, Eltze E et al (2006) Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 66:8959-8965 (Pubitemid 44521111)
33. Stamey TA, McNeal JE, Yemoto CM et al (1999) Biological determinants of cancer progression in men with prostate cancer. JAMA 281:1395-1400 (Pubitemid 29190217)
34. Cheng L, Koch MO, Juliar BE et al (2005) The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 23:2911-2917 (Pubitemid 46224109)
35. Cheng L, Davidson DD, Lin H et al (2007) Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy. Cancer 110:1967-1972 (Pubitemid 350036855)
36. Abdollah F, Schmitges J, SunMet al (2011) Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy. Urology 78:1363-1367
37. Allaf ME, Palapattu GS, Trock BJ et al (2004) Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172:1840-1844 (Pubitemid 39363069)
38. von Bodman C, Godoy G, Chade DC et al (2010) Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. J Urol 184:143-148
39. Ross HM, Kryvenko ON, Cowan JE et al (2012) Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? Am J Surg Pathol 36:1346-1352
40. Fine SW, AminMB, Berney DMet al (2012) A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens. Eur Urol 62:20-39